| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $5.79B | +31.4% |
| Cost of Revenue | $3.34B | +31.2% |
| R&D Expense | $397.1M | -28.6% |
| SG&A Expense | $937.3M | +7.6% |
| Operating Income | -$118.9M | +75.0% |
| Pre-tax Income | $25.4M | +107.6% |
| Income Tax | $2.6M | -70.2% |
| Net Income | $22.8M | +106.7% |
| EPS (Basic) | $0.06 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $759.3M | +35.9% |
| Short-term Investments | $1.23B | +8.8% |
| Current Assets | $2.95B | +14.5% |
| Total Assets | $5.44B | +19.1% |
| Current Liabilities | $3.88B | +31.0% |
| Long-term Debt | $995.0M | +15.0% |
| Total Liabilities | $4.67B | +16.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $849.7M | +964.9% |
| Investing Cash Flow | -$518.0M | -186.4% |
| Financing Cash Flow | -$155.9M | -27.7% |
| +106.8% |
| EPS (Diluted) | $0.06 | +106.8% |
| Stockholders' Equity |
| $767.0M |
| +41.6% |